Collect. Czech. Chem. Commun. 2005, 70, 1482-1492
https://doi.org/10.1135/cccc20051482

Receptor-Based 3D QSAR Analysis of Serotonin 5-HT1D Receptor Agonists

Nalan Terzioglua,* and Hans-Dieter Höltjeb

a Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Istanbul University, 34452, Istanbul, Turkey
b Institute for Pharmaceutical Chemistry, Heinrich-Heine Universität Düsseldorf, D-40225 Düsseldorf, Germany

References

1a. Zifa E., Fillion G.: Pharmacol. Rev. 1992, 44, 401.
1b. Hartig P. R., Adham N., Zgombick J., Weinshank R., Branchek T.: Drug Dev. Res. 1992, 26, 215. <https://doi.org/10.1002/ddr.430260302>
1c. Beer M. S., Middlemiss D. N., McAllister G.: Trends Pharmacol. Sci. 1993, 14, 228. <https://doi.org/10.1016/0165-6147(93)90013-A>
1d. Teitler M.: Med. Chem. Res. 1993, 3, 273.
1e. Bruinvels A. T., Landwehrmeyer B., Probst A., Palacios J. M., Hoyer D.: Mol. Brain Res. 1994, 21, 19. <https://doi.org/10.1016/0169-328X(94)90374-3>
2a. Langer S. Z., Brunello N., Racagni G. Mendlewicz J.: Serotonin Receptor Subtypes: Pharmacological Significance and Clinical Implications. Karger, Basel 1992.
2b. Olivier B., Mos J., van der Heyden J. A. M., Molewijk H. E., van Dijken H. H., Zethof T., Hest A. v., Tulp M. Th. M., Slangen J. L. in: Trends in Receptor Research (V. Claassen, Ed.), p. 97. Elsevier, Amsterdam 1993.
3. Napier C., Stewart M., Melrose H., Hopkins B., McHarg A., Wallis R.: Eur. J. Pharmacol. 1999, 368, 259. <https://doi.org/10.1016/S0014-2999(99)00026-6>
4a. Hoyer D., Martin G.: Neuropharmacology 1997, 36, 419. <https://doi.org/10.1016/S0028-3908(97)00036-1>
4b. Uphouse L.: Neurosci. Biobehav. Rev. 1997, 21, 679. <https://doi.org/10.1016/S0149-7634(96)00022-X>
4c. Saxena P. R., De Vries P., Villalon C. M.: Trends Pharmacol. Sci. 1998, 19, 311. <https://doi.org/10.1016/S0165-6147(98)01228-0>
5a. Leonhardt S., Herrick-Davis K., Titeler M.: J. Neurochem. 1989, 53, 465. <https://doi.org/10.1111/j.1471-4159.1989.tb07357.x>
5b. Parsons A. A.: Trends Pharmacol. Sci. 1991, 12, 310. <https://doi.org/10.1016/0165-6147(91)90583-E>
6. Goadsby P. S.: Drugs 1999, 361.
7. Jandu K. S., Barret V., Bruckwell M., Cambridge D., Farrant D. R., Foster C., Giles H., Glen R. C., Hill A. P., Hobbs H., Honey A., Martin G. R., Salmon J., Smith D., Wollard P., Selwood D. L.: J. Med. Chem. 2001, 44, 681. <https://doi.org/10.1021/jm000956k>
8. Street L. J., Baker R., Davey W. B., Guiblin A. R., Jelley R. A., Reeve A. J., Routledge H., Sternfeld F., Watt A. P., Beer M. S., Middlemiss D. N., Noble A. J., Stanton J. A., Scholey K., Hargreaves R. J., Sohal B., Graham M. I., Matassa V. G.: J. Med. Chem. 1995, 38, 1799. <https://doi.org/10.1021/jm00010a025>
9a. Martin G. R.: Cephalalgia 1997, 17, 4. <https://doi.org/10.1046/j.1468-2982.1997.1703143.x>
9b. Connor H. E., Feniuk W., North P. C., Oxford A. W., Humphrey P. P. A.: Cephalalgia 1997, 17, 145. <https://doi.org/10.1046/j.1468-2982.1997.1703145.x>
9c. Rabasseda X.: Drugs Today 2001, 37, 5. <https://doi.org/10.1358/dot.2001.37.1.844180>
10. Stewart W. F., Lipton R. B., Celentano D. D., Reed M. L.: J. Am. Med. Assoc. 1992, 267, 64. <https://doi.org/10.1001/jama.267.1.64>
11a. Yevich J. P., Yocca F. D.: Curr. Med. Chem. 1997, 4, 295.
11b. Bou J., Domenech T., Puig J., Heredia A., Gras J., Fernandez-Forner D., Beleta J., Palacios J. M.: Eur. J. Pharmacol. 2000, 410, 33. <https://doi.org/10.1016/S0014-2999(00)00876-1>
11c. Johnson D. E., Rollema H., Schmidt A. W., McHarg A. D.: Eur. J. Pharmacol. 2001, 425, 203. <https://doi.org/10.1016/S0014-2999(01)01151-7>
12. Hoskin K. L., Goadsby P. J.: Exp. Neurol. 1998, 150, 45. <https://doi.org/10.1006/exnr.1997.6749>
13a. Trumpp-Kallmeyer S., Bruinvels A., Hoflack J., Hibert M.: Neurochem. Int. 1991, 19, 397. <https://doi.org/10.1016/0197-0186(91)90056-J>
13b. Castro J. L., Baker R., Guiblin A. R., Hobbs S. C., Jenkins M. R., Russel M. G. N., Beer M. S., Stanton J. A., Scholey K., Hargreaves R. J., Graham M. I., Matassa V. G.: J. Med. Chem. 1994, 37, 3023. <https://doi.org/10.1021/jm00045a006>
14. Glen R. C., Martin G. R., Hill A. P., Hyde R. M., Woollard P. M., Salmon J. A., Buckingham J., Robertson A. D.: J. Med. Chem. 1995, 38, 3566.
15. Bremner D. H., Ringan N. S., Wishart G.: Eur. J. Med. Chem. 1997, 32, 59. <https://doi.org/10.1016/S0223-5234(97)84362-0>
16. Chambers M. S., Street L. J., Godacre S. W., Hobbs S. C., Hunt P., Jelley R. A., Matassa V. G., Reeve A. J., Sternfeld F., Beer M. S., Stanton J. A., Rathbone D., Watt A. P., MacLeod A. M.: J. Med. Chem. 1999, 42, 691. <https://doi.org/10.1021/jm980569z>
17a. Kubinyi H.: 3D QSAR in Drug Design: Theory, Methods and Applications. ESCOM, Leiden 1993.
17b. Höltje H.-D., Folkers G.: Molecular Modeling: Basic Principles and Aplications. VCH, Weinheim 1997.
18. Street L. J., Baker R., Castro J. L., Chambers M. S., Guiblin A. R., Hobbs S. C., Matassa V. G., Reeve A. J., Beer M. S., Middlemiss D. N., Noble A. J., Stanton J. A., Scholey K., Hargreaves R. J.: J. Med. Chem. 1993, 36, 1529. <https://doi.org/10.1021/jm00063a003>
19. Deleu D., Hanssens Y.: J. Clin. Pharmacol. 2000, 40, 687. <https://doi.org/10.1177/00912700022009431>
20. SYBYL, version 6.5. TRIPOS Assoc., St. Louis (MO), USA 2002.
21. Hamblin M. W., Metcalf M. A.: Mol. Pharmacol. 1991, 40, 143.
22a. Cruciani G., Watson K. A.: J. Med. Chem. 1994, 37, 2589. <https://doi.org/10.1021/jm00042a012>
22b. Pastor M., Cruciani G., Clementi S.: J. Med. Chem. 1997, 40, 1455. <https://doi.org/10.1021/jm9608016>
22c. Goodford P. J.: J. Med. Chem. 1985, 28, 849. <https://doi.org/10.1021/jm00145a002>
23. GRID, version 16. Molecular Discovery Ltd., Oxford 1985.
24. GOLPE, version 4.0. Multivariate Infometric Analysis, Perugia 1999.
25. Hibert M. F., Trumpp-Kallmeyer S., Bruinvels A., Hoflack J.: Mol. Pharmacol. 1991, 40, 8.